During the past decade, Faculty of Dental Medicine Alazhar University conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Faculty of Dental Medicine Alazhar University" are "TMJ Disc Disorder" (3 trials), "TMD" (2 trials), "Carious Tooth" (1 trials), "Dental Caries" (1 trials) and "Dental Wear" (1 trials). Many other conditions were trialed in "Faculty of Dental Medicine Alazhar University" in a lesser frequency.

Most popular intervention types in "Faculty of Dental Medicine Alazhar University" are "Diagnostic Test" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "MRI" (4 trials), "IPs emax onaly" (1 trials), "TMJ injection" (1 trials), "TMJ injection using patient specific guide" (1 trials) and "Vita Ambria" (1 trials). Other intervention names were less common.

The vast majority of trials in "Faculty of Dental Medicine Alazhar University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Faculty of Dental Medicine Alazhar University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Faculty of Dental Medicine Alazhar University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Faculty of Dental Medicine Alazhar University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".